SCHEMBL25546340

SCHEMBL25546340

CCCc1sc(Cl)nc1-c1cccc(OCC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
CREBBP Q92793 1/20 0.43
FBP1 P09467 1/20 0.43
S1PR1 P21453 4/20 0.43
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
MAPK1 P28482 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25546322 0.88 NOTUM (0.43) NOTUMKMT2AKDM4EALDH1A1HPGD
SCHEMBL25546032 0.85 KMT2A (0.47) NOTUMKMT2AKDM4EALDH1A1HPGD
SCHEMBL25545940 0.85 NOTUM (0.44) NOTUMKMT2AKDM4EALDH1A1HPGD
SCHEMBL25546356 0.78 KDM4E (0.46) KMT2AKDM4EALDH1A1HPGDFBP1
SCHEMBL25546406 0.78 CHEK1 (0.40) NOTUMKMT2AKDM4EALDH1A1HPGD
SCHEMBL25546513 0.77 SMN1; SMN2 (0.47) KMT2AKDM4EFBP1SMN1; SMN2MEN1
SCHEMBL25546355 0.72 FBP1 (0.42) KMT2AKDM4EFBP1SMN1; SMN2DCK
SCHEMBL25546364 0.72 FBP1 (0.45) KMT2AKDM4EHPGDFBP1SMN1; SMN2
SCHEMBL25545933 0.72 TDP1 (0.44) KDM4EALDH1A1HPGDFBP1SMN1; SMN2
SCHEMBL25546361 0.71 FBP1 (0.43) KMT2AFBP1TSHRMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 NOTUM 3220/4885KMT2A 1931/4885KDM4E 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.